Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan in Chinese Patients With Primary Mild and Moderate Hypertension
NCT02609490Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Sep 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azilsartan in hypertension (HTN), sponsored by Lee's Pharmaceutical Holdings Limited. Started Sep 2015; status: completed.
02
Drugs
azilsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02609490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02609490.